Cardio3 BioSciences Has Been Selected to Present C3BS-CQR-1 Trial Data in Late ... MarketWatch (press release) André Terzic, MD, Ph.D, Director at Center of Regenerative Medicine, Mayo Clinic, the co-lead investigator on the trial, will present new final follow up data on the Company's stem cell therapy for heart failure, C3BS-CQR-1, which is based on ... |
